STEM CELL THERAPIES FOR ENTERIC NEUROPATHIES
Dr Lincon Stamp,
Senior Research Fellow & Group Leader,
Department of Anatomy and Physiology,
School of Biomedical Sciences,
The University of Melbourne, Victoria, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | October 2025
Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.
His lab, which he runs together with Dr Marlene Hao, is now focused on the development, plasticity, and cell and gene therapies for the digestive system, with a particular focus on the enteric nervous system.
Dr Stamp has a strong national and international network of collaborators, including key clinical and consumer connections, and has published high impact studies in top tier journals including Gastroenterology, JCI and Nature Reviews Gastroenterology and Hepatology.
He has had success at securing significant government (ARC, MRFF), philanthropic (NSCFA, REACH Foundation) and industry (Takeda Pharmaceuticals) funding, has strong ties within the Australian and international stem cell communities, and is the currently the President of the Australasian Society for Stem Cell Research (ASSCR).
Source: Supplied
https://orcid.org/0000-0002-8925-7894
-
Precision and personalised nutrition
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
-
Anaemia guidelines updated after 50 years
Professor Sant-Rayn Pasricha is the Acting Deputy Director at the Walter Eliza Hall Institute of Medical Research in Melbourne, Australia. He is also a clinical haematologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. From a young age, Prof Pasricha dreamed of becoming a doctor and found joy in learning about the human body and how to care for patients. After completing medical school, he developed a passion for working in low and middle-income countries, which led him to spend time working in East Timor, India, and Central Australia with First Nations communities.
